adult screening programme
Ovarian cancer
The ovaries are a pair of small organs in the female reproductive system. If the ovaries become cancerous the disease can spread to other parts of the reproductive system and the surrounding areas. This includes the womb (uterus), vagina and stomach (abdomen).
» Read more about ovarian cancer on NHS UK
» Read more about ovarian cancer on Cancerbackup
UK NSC screening recommendation
The UK NSC does not recommend screening for ovarian cancer. The committee looked at clinical trial data from the UKCTOCS trial. Women in this trial were screened for ovarian cancer. Data showed the number of women who were still alive 11 years after being screened. In this trial screening did not reduce the number of women who had died from ovarian cancer.
The trial will continue to follow the women who were screened. The committee agreed to review longer term results when they are published.
Supporting documents from the 2017 review
Evidence summary Ovarian cancer (2016)
This document provides the evidence on which the current UK NSC recommendation is based.
Review cycle
Date previous review completed: 2017
Next review estimated to be completed: 2021 to 2022.
To see previous evidence reviews, visit the UK NSC archive.
Organisations interested in Ovarian cancer
These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
List of organisations
- British Association of Surgical Oncology
- Cancer Research UK
- Faculty of Public Health
- Macmillan
- Northern Ireland Cancer Network
- Ovacome
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Pathologists
- Royal College of Physicians
- Royal College of Physicians and Surgeons of Glasgow
- Royal College of Physicians of Edinburgh
- Royal College of Radiologists
- Royal College of Surgeons
- Royal College of Surgeons of Edinburgh
- Society of Radiographers
- The British Association for Cancer Research
- Yorkshire Cancer Research
If you think your organisation should be added, please contact us.